Whitehawk Therapeutics (WHWK) Cash from Investing Activities (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.34% |
| Dec 31, 2025 | 118.39% |
| Sep 30, 2025 | -217.86% |
| Jun 30, 2025 | -124.96% |
| Mar 31, 2025 | 779.45% |
| Dec 31, 2024 | 158.27% |
| Sep 30, 2024 | 242.40% |
| Jun 30, 2024 | -133.83% |
| Mar 31, 2024 | 189.26% |
| Dec 31, 2023 | -71.19% |
| Sep 30, 2023 | -74.95% |
| Jun 30, 2023 | 209.64% |
| Mar 31, 2023 | 119.35% |
| Dec 31, 2022 | -74.90% |
| Sep 30, 2022 | -19,917.84% |
| Jun 30, 2022 | -947.83% |
| Mar 31, 2022 | 50.00% |
| Dec 31, 2021 | -100.18% |
| Dec 31, 2019 | 100.02% |
| Sep 30, 2019 | 96.41% |
| Jun 30, 2019 | -5.39% |
| Mar 31, 2019 | -1,227.74% |
| Dec 31, 2018 | 59.14% |
| Mar 31, 2018 | -117.83% |
| Jun 30, 2017 | -96.51% |
| Jun 30, 2016 | 97.42% |